U.S. Sees 25% Rise in Drug Denials; Sarepta Gene Therapy Deaths; Medicaid Data Access for ICE
Prescription drug denials by private insurers rise 25% (2016-2023). Sarepta gene therapy linked to patient deaths. ICE gains Medicaid data access. ACA insurers seek 2026 rate hikes. Implications for U.S. insurance, regulatory compliance, and patient access.